The results obtained from MCF-7 cells modified to overexpress IGFBP-6 demonstrate that the observed protective effect of IGFBP-6 in ER-positive breast cancer is dependent on adequate PR expression and further supports our conclusion that IGFBP-6 expression improves overall survival in breast cancer patients via a PR-dependent mechanism. The gene discussed is IGFBP6; the disease is breast cancer.